KCNK9 8q24 Variant — Adrenal Potassium Channel Tone and Blood Pressure
The KCNK9 gene encodes TASK3, a two-pore domain background potassium channel11 two-pore domain background potassium channel
K2P channel:
always-open K⁺ leak channels that set the resting membrane potential of excitable and
secretory cells that is highly expressed in the
adrenal zona glomerulosa — the thin outer layer of the adrenal cortex responsible for
producing aldosterone. Aldosterone is the steroid hormone that tells the kidneys to retain
sodium and water, raising blood volume and therefore blood pressure. When TASK3 channel
activity is reduced, zona glomerulosa cells depolarize, increasing calcium influx and
stimulating excess aldosterone synthesis. rs6997709 sits approximately 433 kilobases
upstream of KCNK9 in an intergenic region that may influence KCNK9 expression through
long-range regulatory elements, and its T allele was flagged as a suggestive hypertension
signal in the landmark 2007 Wellcome Trust Case Control Consortium (WTCCC) genome-wide
association study.
The Mechanism
TASK3 (KCNK9) and its close relative TASK1 (KCNK3) together produce the background K⁺
conductance that sets the resting membrane potential of adrenal glomerulosa cells.
Bandulik et al. 201022 Bandulik et al. 2010
Bandulik S et al. TASK1 and TASK3 potassium channels: determinants
of aldosterone secretion and adrenocortical zonation. Horm Metab Res 2010
showed that these channels are molecular targets of angiotensin II signalling: when
angiotensin II binds its receptor, it closes these channels, depolarizes the membrane, and
opens voltage-gated calcium channels to drive aldosterone secretion. Genetically reducing
this channel tone — as in Kcnk9-knockout mice — produces autonomous aldosterone excess and
elevated blood pressure even without elevated renin.
rs6997709 is an intergenic regulatory variant; it does not change the TASK3 protein itself. Its position ~433 kb upstream of KCNK9 places it in a region that may harbour enhancer elements with long-range chromatin contacts to the KCNK9 promoter. The T allele may reduce TASK3 expression, tilting the zona glomerulosa toward a more depolarized resting state and enhanced aldosterone responsiveness.
The Evidence
The WTCCC 2007 genome-wide association study33 WTCCC 2007 genome-wide association study
Wellcome Trust Case Control Consortium.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared
controls. Nature 2007 identified rs6997709 as a
suggestive hypertension signal in a British population (n ~2,000 hypertensive cases, ~3,000
controls). A Korean replication study (Hong et al. 2009)44 Korean replication study (Hong et al. 2009)
Hong KW et al. Replication of
the WTCCC genome-wide association study on essential hypertension in a Korean population.
Hypertens Res 2009 found rs6997709 associated
with systolic blood pressure in a continuous trait analysis, though it did not reach
case-control significance, consistent with a modest additive effect on BP rather than a
binary hypertension switch.
Mechanistic support comes from a study by Jung et al. 201255 Jung et al. 2012
Jung J et al. Variations in
the potassium channel genes KCNK3 and KCNK9 in relation to blood pressure and aldosterone
production. J Clin Endocrinol Metab 2012 that
examined 74 KCNK9 SNPs in 795 participants: multiple KCNK9 variants associated with
systolic blood pressure in African Americans and with aldosterone production indices in
both European and African Americans, placing the KCNK9 locus within the aldosterone
pathway that links potassium channel genetics to blood pressure.
A 2025 nutrigenetics scoping review Holzbach et al. 202566 Holzbach et al. 2025
Holzbach LC et al. Nutrigenetics
and Nutritional Strategies in Systemic Arterial Hypertension. Nutr Rev 2025
identified rs6997709 among 13 SNPs with documented interactions with dietary sodium intake
and blood pressure, consistent with an aldosterone-mediated salt-sensitivity mechanism.
The evidence level is moderate: the original GWAS signal was suggestive rather than genome-wide significant, and the biological mechanism (regulatory effect on KCNK9 expression) has not yet been confirmed by eQTL studies at this specific locus.
Practical Actions
For T-allele carriers, the most relevant lever is dietary sodium. If the KCNK9 locus reduces aldosterone-suppressing channel tone, then high sodium intake may be more pressor for T carriers than for GG individuals. Specifically:
- Restrict dietary sodium to below 2,000 mg/day (roughly 5 g salt), a threshold that clinical guidelines already recommend for hypertension management but that carries extra weight here given the gene-sodium interaction evidence.
- Monitor blood pressure proactively — home blood pressure monitoring provides higher-resolution data than clinic visits and can detect masked or white-coat hypertension.
- Monitor aldosterone-to-renin ratio (ARR) if blood pressure is consistently elevated despite dietary intervention, as the mechanistic model predicts aldosterone-driven low-renin hypertension rather than classical renin-dependent hypertension.
Interactions
The strongest compound interaction partner is GNB3 rs5443, which also showed sodium-interaction in the same scoping review and is a well-established modulator of blood pressure in salt-sensitive populations. ACE rs4646994 and NOS3 rs2070744 interact with the same aldosterone-renin-angiotensin axis; individuals carrying risk variants at multiple loci in this pathway may have additive hypertension susceptibility.
Within the KCNK9 gene itself, rs888345 is the KCNK9 intronic variant most strongly associated with blood pressure in African Americans and with aldosterone production indices in both Europeans and African Americans; it may be in partial linkage disequilibrium with rs6997709 in some populations.